Gain in net survival from hypertension control over the last half-century

Author:

Lantelme Pierre123ORCID,Moulayat Chahinaz123,Courand Pierre-Yves123,Mouly-Bertin Carine123,Debouzy-Berge Constance123,Rial Marie-Odile123,Iwaz Jean1456,Harbaoui Brahim123ORCID,Riche Benjamin1456,Rabilloud Muriel1456

Affiliation:

1. Université de Lyon, Lyon, France

2. Service de Cardiologie, Hôpital de la Croix-Rousse and Hôpital Lyon Sud, Hospices Civils de Lyon, 103 Grande Rue de la Croix-Rousse, 69004 Lyon, France

3. CREATIS (CNRS UMR 5220, INSERM U1044, Université Lyon 1, INSA Lyon), Lyon, France

4. Université Lyon 1, Villeurbanne, France

5. Service de Biostatistique-Bioinformatique, Pôle Santé Publique, Hospices Civils de Lyon, Lyon, France

6. Équipe Biostatistique-Santé, Laboratoire de Biométrie et Biologie Évolutive, CNRS UMR5558, Villeurbanne, France

Abstract

Abstract Aims This study determined whether the improvements in hypertension management over the last five decades have influenced subjects’ prognosis. Methods and results  The study considered 5693 eligible subjects seen January 1969 to February 1991 (follow-up until December 2003) or January 1995 to October 2014 (follow-up until July 2016) in an all-grade hypertension reference centre. Missing data or incomplete follow-ups led to exclude 1036 subjects (18%). The outcome was all-cause death. An adjusted modelling of the excess mortality rate assessed subjects’ net survival over five inclusion periods to allow for the increase in life expectancy of the general population during the same periods. The analysis of 4657 records (mean age: 47 years; 43.2% women) showed that the proportion of subjects with grade 3 hypertension decreased significantly from 43.3% (1142) to only 6.3% (22) over the five periods and that the net survival improved in men and women regardless of the hypertension grade; i.e. the gain in net survival at 15 years was estimated at 12.3% (95% confidence interval: 8.1–22.3). The 15-year restricted mean survival was estimated at 13 years over the first period and 14.8 years over the last period, which is nearly a 2-year gain in life expectancy at 15 years. Conclusion  Since the 70s and the advent of modern management, the excess mortality of hypertensive subjects (vs. the general population) was markedly reduced. Within a context of trivialization of blood pressure measurement and reluctance to long-term treatments, physicians should consider this advantage and use it to promote blood pressure control.

Publisher

Oxford University Press (OUP)

Subject

Cardiology and Cardiovascular Medicine,Epidemiology

Reference31 articles.

1. Timeline of history of hypertension treatment;Saklayen;Front Cardiovasc Med,2016

2. Global disparities of hypertension prevalence and control: a systematic analysis of population-based studies from 90 countries;Mills;Circulation,2016

3. L’hypertension artérielle en France: prévalence, traitement et contrôle en 2015 et évolutions depuis 2006;Perrine;Bull Epidémiol Hebdomad,2018

4. Trends in blood pressure control among US adults with hypertension, 1999-2000 to 2017-2018;Muntner;JAMA,2020

5. Association between protein intake and mortality in hypertensive patients without chronic kidney disease in the OLD-HTA Cohort;Courand;Hypertension,2016

Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3